GlassScriptPhysician profile
Lindsay Smith
NPI 1366485369
$8,789.91
in general payments reported to CMS, 2019-2025
55 companies · $1,541 in 2025
The $1,541 reported for 2025 was more than what 87% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,364 · 2022: $1,704 · 2023: $2,002 · 2024: $1,179 · 2025: $1,541.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,697 · Education: $25.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,697.01 |
| Education | $25.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,487.56 | 2021-2025 | |
| Lilly USA, LLC | $974.27 | 2021-2025 | Mounjaro, Jardiance, Zepbound |
| Takeda Pharmaceuticals U.S.A., INC. | $695.66 | 2021-2023 | Trintellix |
| Novo Nordisk INC | $430.83 | 2021-2025 | Wegovy, Ozempic, Rybelsus |
| Pfizer INC. | $427.28 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $409.50 | 2021-2025 | Airsupra, Farxiga, Breztri |
| Dexcom, INC. | $382.21 | 2021-2025 | Dexcom G6 Transmitter |
| Glaxosmithkline, LLC. | $358.76 | 2021-2025 | Trelegy Ellipta, Shingrix |
| Corium, LLC | $300.44 | 2022-2024 | Azstarys |
| Boehringer Ingelheim Pharmaceuticals, INC. | $253.45 | 2021-2025 | Jardiance |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $230.05 | 2021-2025 | Xifaxan |
| Paratek Pharmaceuticals, INC. | $191.48 | 2021-2024 | Nuzyra |
| Axsome Therapeutics, INC. | $186.35 | 2023-2025 | Auvelity |
| Optos, INC. | $159.03 | 2021 | |
| Idorsia Pharmaceuticals US INC | $153.64 | 2022-2024 | Quviviq |
Show all 55 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $153.10 | 2022-2025 | Rexulti |
| Bayer Healthcare Pharmaceuticals INC. | $142.24 | 2022-2025 | |
| Medtronic, INC. | $128.89 | 2023-2025 | Intellis Adaptivestim, Corevalve Evolut R, Symplicity G3 |
| Biohaven Pharmaceuticals, INC. | $120.64 | 2021 | |
| Amgen INC. | $116.56 | 2021-2025 | Prolia, Evenity, Repatha |
| Exact Sciences Corporation | $111.41 | 2023-2025 | Cologuard Collection Kit |
| Genentech USA, INC. | $107.63 | 2021-2022 | |
| Tris Pharma INC | $94.47 | 2023 | Dyanavel Xr |
| Amarin Pharma, INC. | $85.04 | 2021 | |
| Merck Sharp & Dohme LLC | $66.08 | 2021-2024 | Gardasil 9, Gardasil |
| Jazz Pharmaceuticals INC. | $65.53 | 2021-2022 | |
| Gilead Sciences, INC. | $62.58 | 2021-2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $61.97 | 2022 | |
| Ironshore Pharmaceuticals INC. | $60.75 | 2021-2023 | Jornay Pm |
| Nevro Corp. | $57.87 | 2023-2024 | Senza |
| Currax Pharmaceuticals LLC | $56.36 | 2023 | Nexletol, Onzetra Xsail, Contrave |
| Abbott Laboratories | $55.37 | 2022-2023 | Freestyle Libre 3 |
| Lundbeck LLC | $52.00 | 2022-2023 | Rexulti |
| Esperion Therapeutics, INC. | $48.41 | 2021 | |
| Tolmar, INC. | $46.50 | 2023-2024 | |
| Kowa Pharmaceuticals America, INC. | $43.53 | 2022-2025 | Zoryve |
| Boston Scientific Corporation | $41.44 | 2023 | Watchman Flx |
| Horizon Therapeutics Plc | $37.17 | 2021-2022 | |
| Hologic Sales and Service, LLC | $30.06 | 2025 | Aptima |
| Evofem Biosciences, INC. | $27.12 | 2022 | |
| Janssen Pharmaceuticals, INC | $25.16 | 2021-2022 | |
| Inspire Medical Systems, INC. | $24.55 | 2024 | Inspire |
| Vertex Pharmaceuticals Incorporated | $24.15 | 2025 | |
| Ironwood Pharmaceuticals, INC | $21.66 | 2022 | |
| Azurity Pharmaceuticals, INC. | $21.33 | 2023 | Edarbi |
| Allergan, INC. | $21.03 | 2022 | |
| Sumitomo Pharma America, INC. | $19.44 | 2025 | Gemtesa |
| Ardelyx, INC. | $18.58 | 2024 | Ibsrela |
| Acella Pharmaceuticals, LLC | $17.55 | 2025 | NP Thyroid 60 |
| Eisai INC. | $16.32 | 2021 | |
| Vivus LLC | $14.59 | 2025 | Pancreaze |
| Antares Pharma, INC. | $13.84 | 2024 | Xyosted |
| Spinal Simplicity, LLC | $13.72 | 2022 | |
| Philips North America LLC | $13.29 | 2024 | (Ak6) Vest Therapy |
| Ibsa Pharma INC. | $11.47 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lindsay Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.